A detailed history of Pacific Center For Financial Services transactions in Abb Vie Inc. stock. As of the latest transaction made, Pacific Center For Financial Services holds 2,628 shares of ABBV stock, worth $440,873. This represents 0.15% of its overall portfolio holdings.

Number of Shares
2,628
Previous 2,616 0.46%
Holding current value
$440,873
Previous $448,000 15.63%
% of portfolio
0.15%
Previous 0.14%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$163.84 - $199.33 $1,966 - $2,391
12 Added 0.46%
2,628 $518,000
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $2,321 - $2,711
15 Added 0.58%
2,616 $448,000
Q1 2024

May 20, 2024

BUY
$159.82 - $182.1 $2,077 - $2,367
13 Added 0.5%
2,601 $473,000
Q4 2023

Feb 20, 2024

BUY
$137.6 - $154.97 $2,201 - $2,479
16 Added 0.62%
2,588 $401,000
Q3 2023

Nov 15, 2023

BUY
$133.59 - $154.65 $1,870 - $2,165
14 Added 0.55%
2,572 $383,000
Q2 2023

Aug 09, 2023

BUY
$132.51 - $164.9 $1,987 - $2,473
15 Added 0.59%
2,558 $344,000
Q1 2023

May 16, 2023

BUY
$144.61 - $166.54 $3,904 - $4,496
27 Added 1.07%
2,543 $405,000
Q3 2022

Nov 10, 2022

BUY
$134.21 - $153.93 $1,878 - $2,155
14 Added 0.56%
2,516 $338,000
Q2 2022

Aug 12, 2022

BUY
$137.62 - $174.96 $146,290 - $185,982
1,063 Added 73.87%
2,502 $383,000
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $644 - $815
6 Added 0.42%
1,439 $195,000
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $52,987 - $60,148
498 Added 53.26%
1,433 $155,000
Q4 2020

Feb 18, 2021

BUY
$80.49 - $108.67 $8,934 - $12,062
111 Added 13.47%
935 $100,000
Q2 2020

Aug 06, 2020

BUY
$73.37 - $98.18 $33,309 - $44,573
454 Added 122.7%
824 $81,000
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $25,844 - $33,011
370
370 $33,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $297B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Pacific Center For Financial Services Portfolio

Follow Pacific Center For Financial Services and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pacific Center For Financial Services, based on Form 13F filings with the SEC.

News

Stay updated on Pacific Center For Financial Services with notifications on news.